免疫調節におけるLycium barbarumのポリサッカリドの構造活動関係: 治療開発のための標的識別と分子洞察を統合する
Bo Wang1, Jie Yang1, Lijun Tao1
1People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, China.
Frontiers in immunology
|February 11, 2026
まとめ
リシウムバーバラムのポリサッカリド (LBP) は,免疫調節の可能性を示しています. 最適な活動は,中等分子量と特定の糖分と関連しており,免疫細胞応答と治療用途の腸内微生物群に影響を与えます.
科学分野:
- * 免疫学と天然製品化学
- * Lycium barbarum (LBP) のポリサッカリドに注目する.
背景:
- * Lycium barbarum polysaccharides (LBP) の確立された免疫調節能力について.
- * 治療の進歩のために,構造-活動関係 (SAR) の明確化の必要性.
研究 の 目的:
- * LBPの構造と活動の関係に関する現在の知識をレビューし,統合する.
- * LBPの構造パラメータが免疫調節機能にどのように影響するか解明する.
主な方法:
- * LBPに関する既存の研究を統合した文献レビュー.
- *構造パラメータの分析:分子量,モノサッカリド組成,グリコシド結合,化学変化.
- * LBPの直接的・間接的免疫調節メカニズムの検討.
主要な成果:
- *中等分子量LBP (10^5-10^6Da) は,パターン認識受容体 (PRRs) に多価結合することによって最適な免疫調節活性を示します.
- * アラビノースとギャラクトースの含有量が高く,特にアラビノギャラクタンのような構造は,免疫細胞の活性化に不可欠です.
- *LBPは,マクロファージの偏分 (STAT1/STAT6),デンドリット細胞の成熟 (NF-κB,Notch),T細胞の分化を調節する.
- *LBPは,腸内微生物群と短鎖脂肪酸の産生を調節することによって,免疫に間接的に影響を及ぼします.
結論:
- *LBPの免疫調節効果は複雑で,特定の構造的特徴に依存しています.
- *SARに基づくLBPの標準化は,精密免疫調節剤の開発に不可欠です.
- * 臨床翻訳には,LBP製剤の異質性に対処する必要があります.
関連する概念動画
Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Local Anesthetics: Chemistry and Structure-Activity Relationship
6.7K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.7K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.8K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.0K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.2K


